Similar articles

• An experimental immunoscintigraphic study with anti-CEA monoclonal antibody (DG2).

  Koprivová H, Novák F, Poucková P, Svihovcová P, Jantscheff P, Bötgger V, Micheel B, Dvorák P, Seblová J, Pospísil J, et al. Koprivová H, et al. Neoplasma. 1990;37(1):3-11. Neoplasma. 1990. PMID: 2320177
• BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.

  Parisi A, Bartolazzi A, Bonino C, Camagna M, DeMonte LB, Lombardi A, Natali PG, Paganelli G, Tarditi L, Vassarotto C, et al. Parisi A, et al. Year Immunol. 1993;7:96-105. Year Immunol. 1993. PMID: 8372516 No abstract available.
• 131I-labelled tumour-specific antibodies: trial to concentrate radioisotopes specifically in tumours. 3. Improved radioimaging and tumour localization in nude mice with a monoclonal anti-CEA antibody by preincubation of labelled antibody with syngeneic spleen cells. (A rapid communication).

  Makidono R, Ayabe Z, Matsuura K, Shiozaki H, Makidono A. Makidono R, et al. Nihon Igaku Hoshasen Gakkai Zasshi. 1985 Feb 25;45(2):388-92. Nihon Igaku Hoshasen Gakkai Zasshi. 1985. PMID: 4011413 No abstract available.
• Carcinoembryonic antigen as a target cancer antigen for radiolabeled antibodies: prospects for cancer imaging and therapy.

  Goldenberg DM. Goldenberg DM. Tumour Biol. 1995;16(1):62-73. doi: 10.1159/000217930. Tumour Biol. 1995. PMID: 7863224 Review.
• Preclinical models and methods for the study of radiolabeled monoclonal antibodies in cancer diagnosis and therapy.

  Shah SA, Sands H. Shah SA, et al. Cancer Treat Res. 1990;51:53-96. doi: 10.1007/978-1-4613-1497-4_4. Cancer Treat Res. 1990. PMID: 1977460 Review. No abstract available.